Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-response Effect of Pine Nut Oil as a Dual FFA1 and FFA4 Agonist on Glucose Tolerance, Incretins, Appetite and Tolerability in Healthy Humans.

NCT03305367 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT03305367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03305367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-response Effect of Pine Nut Oil as a Dual FFA1 and FFA4 Agonist on Glucose Tolerance, Incretins, Appetite and Tolerability in Healthy Humans.
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 6, 2017
Completion date
August 23, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus